These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 329987)

  • 21. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of vindesine administration by bolus injection and by 24-hour infusion.
    Gilby ED
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():47-51. PubMed ID: 7438121
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
    Barnett CJ; Cullinan GJ; Gerzon K; Hoying RC; Jones WE; Newlon WM; Poore GA; Robison RL; Sweeney MJ; Todd GC; Dyke RW; Nelson RL
    J Med Chem; 1978 Jan; 21(1):88-96. PubMed ID: 412968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update results of vindesine as a single agent in the therapy of advanced malignant melanoma.
    Retsas S; Peat I; Ashford R; Coe M; Maher J; Drury A; Hanham IW; Phillips RH; Newton KA; Westbury G
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():87-90. PubMed ID: 7438128
    [No Abstract]   [Full Text] [Related]  

  • 25. A multicentre phase II trial of vindesine in malignant melanoma.
    Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A cooperative phase II study of vindesine sulfate in patients with solid tumors].
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2036-42. PubMed ID: 6614938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I and II studies of vindesine.
    Valdivieso M
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():31-7. PubMed ID: 7438119
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy of carcinoma of the respiratory and digestive tracts with vindesine sulfate. Phase II clinical trial].
    Domenge C; Richard JM
    Ann Otolaryngol Chir Cervicofac; 1984; 101(2):119-21. PubMed ID: 6372615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inapparent infiltrations associated with vindesine administration.
    Dorr RT; Jones SE
    Med Pediatr Oncol; 1979; 6(4):285-8. PubMed ID: 481319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental antitumor activity of Navelbine.
    Cros S; Wright M; Morimoto M; Lataste H; Couzinier JP; Krikorian A
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):15-20. PubMed ID: 2711203
    [No Abstract]   [Full Text] [Related]  

  • 31. Vindesine-associated angina and ECG changes.
    Yancey RS; Talpaz M
    Cancer Treat Rep; 1982 Mar; 66(3):587-9. PubMed ID: 7060049
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms.
    Stolinsky DC; Hum GJ; Jacobs EM; Solomon J; Bateman JR
    Cancer Chemother Rep; 1973; 57(4):477-80. PubMed ID: 4586954
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys.
    Sethi VS; Surratt P; Spurr CL
    Cancer Chemother Pharmacol; 1984; 12(1):31-5. PubMed ID: 6690071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay.
    Owellen RJ; Blair M; Van Tosh A; Hains FC
    Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vindesine: a new antineoplastic drug].
    Baccarani M; Corbelli G
    G Clin Med; 1981 Feb; 62(2):129-34. PubMed ID: 7016650
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
    Wong PP; Yagoda A; Currie VE; Young CW
    Cancer Treat Rep; 1977 Dec; 61(9):1727-9. PubMed ID: 340038
    [No Abstract]   [Full Text] [Related]  

  • 37. An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood.
    Krivit W; Chilcote R; Pyesmany A; Anderson J; Hammond D
    Cancer Chemother Pharmacol; 1979; 2(4):267-70. PubMed ID: 287570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs.
    Todd GC; Gibson WR; Morton DM
    J Toxicol Environ Health; 1976 May; 1(5):843-50. PubMed ID: 1271489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EORTC phase II trial of vindesine in advanced melanoma.
    Rümke P; Everall JD; Mulder JH; Rozencweig M; Czarnetzki B; Thomas D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1173-4. PubMed ID: 6684562
    [No Abstract]   [Full Text] [Related]  

  • 40. Vindesine: a phase II study in childhood malignancies-a report for cancer and leukemia group B.
    Ettinger LJ; Brecher M; Coleman M; Smithson WA; Patterson R; Russell EC; Necheles T; Jones B; Ohnuma T
    Med Pediatr Oncol; 1982; 10(1):35-43. PubMed ID: 7038420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.